Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe(®) in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE Study.
- DOI
- 10.1007/s40801-025-00522-w
- Published
- 2025 Dec
- Container
- Drugs - real world outcomes
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40801-025-00522-w,
title = {Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe(®) in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE Study.},
author = {Balamurugan S and Pophale H and Samariya U and Apte K and Singh S and Dhar R and Rajan S and Swarnakar R and Talwar D and Lopez M and Naik V and Sawant S and Chhowala S and Vaidya A and Gogtay J},
year = {2025},
journal = {Drugs - real world outcomes},
doi = {10.1007/s40801-025-00522-w},
url = {https://doi.org/10.1007/s40801-025-00522-w}
}RIS
TY - JOUR TI - Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe(®) in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE Study. AU - Balamurugan S AU - Pophale H AU - Samariya U AU - Apte K AU - Singh S AU - Dhar R AU - Rajan S AU - Swarnakar R AU - Talwar D AU - Lopez M AU - Naik V AU - Sawant S AU - Chhowala S AU - Vaidya A AU - Gogtay J PY - 2025 JO - Drugs - real world outcomes DO - 10.1007/s40801-025-00522-w UR - https://doi.org/10.1007/s40801-025-00522-w ER -
APA
S, B., H, P., U, S., K, A., S, S., R, D., S, R., R, S., D, T., M, L., V, N., S, S., S, C., A, V., & J, G. (2025). Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe(®) in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE Study.. Drugs - real world outcomes. https://doi.org/10.1007/s40801-025-00522-w
Source records
- pubmed · retrieved 2026-09-26T03:19:45.323Z